Natural Product-Based Synthetic Drug Molecules in Alzheimer's Disease : Therapeutic and Theranostic Agents
Intro -- Preface -- Contents -- Editors and Contributors -- Part I: Introduction of Alzheimer´s Disease -- 1: Alzheimer´s Disease and Drug Targets -- 1.1 Introduction -- 1.2 Pathological and Therapeutic Target in AD -- 1.2.1 Amyloid Beta (Aβ) -- 1.2.2 Tau Phosphorylation -- 1.3 Mitochondrial Dysfunction and Oxidative Stress in Alzheimer´s Disease -- 1.3.1 Alzheimer´s Disease Drug Targets -- 1.3.1.1 Prevention of Aβ Accumulation and Amyloid Inhibitors -- 1.3.1.2 Prevention of Tau Protein Phosphorylation -- 1.3.1.3 MicroRNAs in the Management of AD -- 1.3.1.4 Pyroglutamate Aβ Cascade as a Potential Target -- 1.3.1.5 Immunotherapy in Alzheimer´s Disease -- References -- 2: Oxidative Stress and Metals in Alzheimer´s Disease -- 2.1 Introduction -- 2.2 Oxidative Stress -- 2.2.1 Oxidative Stress and Neurodegeneration -- 2.2.2 Relation Between Oxygen and Oxidative Stress -- 2.2.3 Mechanism of Generation of Reactive Oxygen Species (ROS) -- 2.2.4 Role of Amyloid Beta (Aβ)-Induced Oxidative Stress in Alzheimer´s Disease (AD) -- 2.2.5 Oxidative Damage-Induced Tau Neurofibrillary Tangles -- 2.3 ROS-Induced Disruption of Calcium Signalling in Alzheimer´s Disease -- 2.4 ROS-Induced Mitochondrial Dysfunction (Mitochondrial Cascade Hypothesis) -- 2.5 Oxidative Stress and Damage to Biomolecules (Lipids, Proteins, DNA/RNA) -- 2.6 Role of Metals in AD -- 2.7 Zinc -- 2.8 Iron Toxicity -- 2.9 Copper Toxicity -- 2.10 Aluminium -- 2.11 Manganese -- 2.12 Cadmium -- 2.13 Lead -- 2.14 Conclusion -- References -- 3: Neuroinflammation in Alzheimer´s Disease -- 3.1 Introduction -- 3.2 Epidemiology -- 3.3 Neuroinflammation -- 3.3.1 Etiology -- 3.4 Mechanism of Neuroinflammation in AD -- 3.4.1 Microglial Activation -- 3.4.1.1 MyD88-Dependent Pathways -- 3.4.1.2 Activation of MyD88-Independent Pathways -- 3.4.2 Activation of Astrocytes -- 3.4.3 Damage to Cell Membrane..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2024 ©2023 |
---|---|
Erschienen: |
Singapore: Springer ; 2024 ©2023 |
Ausgabe: |
1st edition |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sharma, Abha [HerausgeberIn] |
---|
Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
---|
ISBN: |
---|
Anmerkungen: |
Description based on publisher supplied metadata and other sources |
---|
Umfang: |
1 Online-Ressource (447 Seiten) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1879435004 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1879435004 | ||
003 | DE-627 | ||
005 | 20240201134742.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240129s2024 xx |||||o 00| ||eng c | ||
020 | |a 9789819960385 |9 978-981-99-6038-5 | ||
035 | |a (DE-627)1879435004 | ||
035 | |a (DE-599)KEP09971695X | ||
035 | |a (EBC)EBC31020172 | ||
035 | |a (EBL)EBL31020172 | ||
035 | |a (EBP)09971695X | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | |a 616.8311061 | |
245 | 1 | 0 | |a Natural Product-Based Synthetic Drug Molecules in Alzheimer's Disease |b Therapeutic and Theranostic Agents |
250 | |a 1st edition | ||
264 | 1 | |a Singapore |b Springer |c 2024 | |
264 | 4 | |c ©2023 | |
300 | |a 1 Online-Ressource (447 Seiten) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
520 | |a Intro -- Preface -- Contents -- Editors and Contributors -- Part I: Introduction of Alzheimer´s Disease -- 1: Alzheimer´s Disease and Drug Targets -- 1.1 Introduction -- 1.2 Pathological and Therapeutic Target in AD -- 1.2.1 Amyloid Beta (Aβ) -- 1.2.2 Tau Phosphorylation -- 1.3 Mitochondrial Dysfunction and Oxidative Stress in Alzheimer´s Disease -- 1.3.1 Alzheimer´s Disease Drug Targets -- 1.3.1.1 Prevention of Aβ Accumulation and Amyloid Inhibitors -- 1.3.1.2 Prevention of Tau Protein Phosphorylation -- 1.3.1.3 MicroRNAs in the Management of AD -- 1.3.1.4 Pyroglutamate Aβ Cascade as a Potential Target -- 1.3.1.5 Immunotherapy in Alzheimer´s Disease -- References -- 2: Oxidative Stress and Metals in Alzheimer´s Disease -- 2.1 Introduction -- 2.2 Oxidative Stress -- 2.2.1 Oxidative Stress and Neurodegeneration -- 2.2.2 Relation Between Oxygen and Oxidative Stress -- 2.2.3 Mechanism of Generation of Reactive Oxygen Species (ROS) -- 2.2.4 Role of Amyloid Beta (Aβ)-Induced Oxidative Stress in Alzheimer´s Disease (AD) -- 2.2.5 Oxidative Damage-Induced Tau Neurofibrillary Tangles -- 2.3 ROS-Induced Disruption of Calcium Signalling in Alzheimer´s Disease -- 2.4 ROS-Induced Mitochondrial Dysfunction (Mitochondrial Cascade Hypothesis) -- 2.5 Oxidative Stress and Damage to Biomolecules (Lipids, Proteins, DNA/RNA) -- 2.6 Role of Metals in AD -- 2.7 Zinc -- 2.8 Iron Toxicity -- 2.9 Copper Toxicity -- 2.10 Aluminium -- 2.11 Manganese -- 2.12 Cadmium -- 2.13 Lead -- 2.14 Conclusion -- References -- 3: Neuroinflammation in Alzheimer´s Disease -- 3.1 Introduction -- 3.2 Epidemiology -- 3.3 Neuroinflammation -- 3.3.1 Etiology -- 3.4 Mechanism of Neuroinflammation in AD -- 3.4.1 Microglial Activation -- 3.4.1.1 MyD88-Dependent Pathways -- 3.4.1.2 Activation of MyD88-Independent Pathways -- 3.4.2 Activation of Astrocytes -- 3.4.3 Damage to Cell Membrane. | ||
700 | 1 | |a Sharma, Abha |e herausgeberin |4 edt | |
700 | 1 | |a Modi, Gyan Prakash |e herausgeberin |4 edt | |
776 | 1 | |z 9789819960378 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819960378 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=31020172 |m X:EBC |x Aggregator |z lizenzpflichtig |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
951 | |a BO | ||
953 | |2 045F |a 616.8311061 | ||
980 | |2 20 |1 01 |x 0084 |b 4472243407 |h CATDESC_EBC-EB |u CATDESC_EBC-EB |y z |z 01-02-24 | ||
981 | |2 20 |1 01 |x 0084 |r https://ebookcentral.proquest.com/lib/tubraunschweig-ebooks/detail.action?docID=31020172 | ||
995 | |2 20 |1 01 |x 0084 |a CATDESC_EBC-EB | ||
995 | |2 20 |1 01 |x 0084 |a ACQ |